About the laboratories
The Laboratoires VIVACY is a French manufacturer specialising in the development, production and distribution of injectable hyaluronic acid-based medical devices for Aesthetic and Anti-ageing Medicine. In 10 years, the Laboratoires VIVACY has become one of the major players on Medical Aesthetics market in Europe and has exported its technological know-how to more than 80 countries around the world.
The VIVACY’s product portfolio includes three main well-established brands: STYLAGE®, DESIRIAL® injectable products and the dermo-cosmetics STYLAGE® SKIN PRO. The company also manufactures HA-based viscosupplements (medical devices) for ophthalmic surgery (I.SPACE®) and for treatment of osteoarthritis (KARTILAGE®). The industrial plant of the company is located in Archamps Technopôle, in the dynamic region of Haute-Savoie, near the French-Swiss border, and has become an institution as a research and development centre at the cutting edge of technology. All VIVACY’s products are exclusively made in France. In 8 years, the company has multiplied by 11 their production capacity, which has now reached 3 million syringes per year.
Creation of the Laboratoires VIVACY.
First CE marking of STYLAGE® products.
First CE marking of STYLAGE® products: STYLAGE® S, STYLAGE® M, STYLAGE® L, and STYLAGE® Hydro.
Opening of the Marketing and Sales Office in Paris.
First CE marking of STYLAGE® with Lidocaïne products.
CE marking of STYLAGE® XL and the STYLAGE® products with Lidocaine: STYLAGE® Special Lips Lidocaïne, STYLAGE® S Lidocaïne and STYLAGE® M Lidocaïne. CE marking of I.SPACE®, medical device for ophthalmic use. Distribution in France of CytoCare® line of products by Laboratoires REVITACARE.
Launch of STYLAGE® HydroMax.
Launch of STYLAGE® HydroMax. Extension of the existing aesthetic range with an anaesthetic: STYLAGE® L Lidocaïne and STYLAGE® XL Lidocaïne.
CE marking of DESIRIAL® & KARTILAGE® ranges.
CE marking of DESIRIAL®, medical devices specifically designed to treat the female intimate area. CE marking of KARTILAGE® viscosupplements for the treatment of joint arthritis.
Launch of STYLAGE® XXL.
Launch of STYLAGE® XXL, for facial volume restoration and augmentation.
Opening of the new production site in Archamps.
Opening of the new production site in Archamps, Haute-Savoie (next to the Swiss border).
Launch of STYLAGE® SKIN PRO.
Launch of STYLAGE® SKIN PRO, the anti-ageing dermocosmetics based on the exclusive VIVASÔME® complex.
Opening of a subsidiary in Geneva.
Opening of a subsidiary in Geneva, VIVACY International SA.
Launch of VIVACY SECURITY® and VIVACY e-LEARN.
Launch of VIVACY SECURITY®, an innovative authentication system allowing the physicians to identify the purchased VIVACY’s injectable products thanks to RFID (Radio Frequency Identification) technology. Launch of the “My Vivacy” App on Apple Store and GooglePlay.
Launch of www.vivacy-learn.com, an e-learning platform developed for physicians and allowing them to follow the advanced injection techniques and intended to promote the physicians’ knowledge, experience and exchange.
Launch of a new-generation injection delivery system, Bi-SOFT® Injection Technology.
Launch of a new-generation injection delivery system, Bi-SOFT® Injection Technology, that provides greater precision, comfort, and control during the injection of STYLAGE® and DESIRIAL® products.
A unique technological expertise
Thanks to their unique technological expertise, the Laboratoires VIVACY has achieved real and rapid success in the field of Aesthetic Medicine. Today, VIVACY is ranked among the World’s Top manufacturers of hyaluronic acid-based medical devices.
In eight years the Laboratories VIVACY has multiplied by 11 their production capacity, which has now reached 3 million syringes per year. The laboratory managed to export their French technological know-how to the rest of the world: 80% of the company’s revenue is generated in international markets. The VIVACY’s injectable products are now being distributed in more than 80 countries around the world.